Novavax’s latest win? A $60M contract for its Covid-19 vaccine

Novavax Inc. just scored even more support for its coronavirus vaccine program. The Gaithersburg company said late Thursday it won a Department of Defense contract worth up to $60 million to help manufacture its Covid-19 vaccine candidate, NVX‑CoV2373. The funding, from the Defense Health Program, would back the production of multiple pieces of the vaccine, to be manufactured in the U.S., according to Novavax’s (NASDAQ: NVAX) announcement. The deal covers 10 million doses this year, which could…